-
Mashup Score: 0Sign Up - 5 year(s) ago
This site uses cookies, tags, and tracking settings to store information that help give you the very best browsing experience. If you don’t change your settings, we’ll assume you’re happy with this. More information Dismiss this warning …
Source: ec.bioscientifica.comCategories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 0Volume 9 (2020): Issue 6 (Jun 2020) - 5 year(s) ago
…
Source: ec.bioscientifica.comCategories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 0Volume 9 (2020): Issue 5 (May 2020) - 5 year(s) ago
This site uses cookies, tags, and tracking settings to store information that help give you the very best browsing experience. If you don’t change your settings, we’ll assume you’re happy with this. More information Dismiss this warning …
Source: ec.bioscientifica.comCategories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 0Impact Factor Collection - 5 year(s) ago
Endocrine Connections’ 2019 Impact Factor has risen to 2.592. This Impact Factor highlights the high-quality, engaging and unique research that the Editorial Board has helped become published to a global audience. To celebrate Endocrine Connections’ new Impact Factor, the journal Editorial Team have compiled a collection of highly cited articles contributing…
Source: ec.bioscientifica.comCategories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 0Impact Factor Collection - 5 year(s) ago
Endocrine Connections’ 2019 Impact Factor has risen to 2.592. This Impact Factor highlights the high-quality, engaging and unique research that the Editorial Board has helped become published to a global audience. To celebrate Endocrine Connections’ new Impact Factor, the journal Editorial Team have compiled a collection of highly cited articles contributing…
Source: ec.bioscientifica.comCategories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 0Prognostic role of lymphocyte-to-monocyte ratio in pancreatic neuroendocrine neoplasms in: Endocrine Connections Volume 9 Issue 4 (2020) - 5 year(s) ago
IntroductionPancreatic neuroendocrine neoplasm (pNEN) is a rare malignancy arising from pancreatic islet cells and accounts for 1–2% of all pancreatic tumors (1). However, with the popularization of abdominal imaging and the promotion of endoscopic ultrasonography, the detection rate of pNEN has increased 4.8-fold and 1.2-fold in the United States and Japan in recent years, respectively (2, 3)….
Source: ec.bioscientifica.comCategories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 0Prognostic role of lymphocyte-to-monocyte ratio in pancreatic neuroendocrine neoplasms in: Endocrine Connections Volume 9 Issue 4 (2020) - 5 year(s) ago
IntroductionPancreatic neuroendocrine neoplasm (pNEN) is a rare malignancy arising from pancreatic islet cells and accounts for 1–2% of all pancreatic tumors (1). However, with the popularization of abdominal imaging and the promotion of endoscopic ultrasonography, the detection rate of pNEN has increased 4.8-fold and 1.2-fold in the United States and Japan in recent years, respectively (2, 3)….
Source: ec.bioscientifica.comCategories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 0Sign Up - 5 year(s) ago
This site uses cookies, tags, and tracking settings to store information that help give you the very best browsing experience. If you don’t change your settings, we’ll assume you’re happy with this. More information Dismiss this warning …
Source: ec.bioscientifica.comCategories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 0Assessment of the iodine nutritional status among Chinese school-aged children in: Endocrine Connections Volume 9 Issue 5 (2020) - 5 year(s) ago
IntroductionIodine deficiency disorders (IDD) indicate the broad range of harmful effects due to low level of thyroid hormones in the blood caused by an inadequate dietary supply of iodine (1, 2). Pregnant women and young children are more vulnerable to iodine deficiency because the former require higher iodine intake to maintain both maternal and neonatal normal neurodevelopment, and the latter…
Source: ec.bioscientifica.comCategories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 0Sacubitril/valsartan increases postprandial gastrin and cholecystokinin in plasma in: Endocrine Connections Volume 9 Issue 5 (2020) - 5 year(s) ago
IntroductionChronic heart failure is treated by inhibition of the sympathetic and the renin-angiotensin-aldosterone system (RAAS). More recently, sacubitril/valsartan has been introduced as treatment for patients with chronic heart failure. The drug is composed of valsartan, an angiotensin-II receptor 1 blocker, and sacubitril, which inhibits the peptide-degrading enzyme neprilysin (neutral…
Source: ec.bioscientifica.comCategories: Endocrinology, Latest HeadlinesTweet
Enjoy reading #OpenAccess endocrinology articles? Signup for the latest content to be emailed direct to your inbox! It's quick, easy and free to read. https://t.co/O67ec2qW3G